Abstract
Predictions of future cases of mesothelioma in Australia to the year 2020 are in the order of a total of 10,000 new cases. Compensation claims are testing the attribution in a particular case between occupational asbestos exposure and lung cancer. The cost of the problem necessitates clarifying and standardizing the criteria for a confident diagnosis of asbestos-related disease. The possibility of differences in criteria that determine attribution of asbestos to a disease prompted a consensus meeting of pathologists, epidemiologists, physicians, oncologists, radiologists, and others to define current thinking and to agree on an Australian document based on the scientific evidence for establishing diagnoses and attribution data of asbestos-related diseases in Australia. The participants' findings are reported.
Publication types
-
Consensus Development Conference
-
Review
MeSH terms
-
Asbestos / adverse effects*
-
Asbestosis / epidemiology
-
Asbestosis / etiology
-
Australia / epidemiology
-
Causality
-
Environmental Pollutants / toxicity*
-
Humans
-
Lung Neoplasms / chemically induced
-
Lung Neoplasms / epidemiology
-
Mesothelioma / chemically induced
-
Mesothelioma / epidemiology
-
Mineral Fibers / adverse effects
-
Occupational Diseases / chemically induced
-
Occupational Diseases / epidemiology
-
Occupational Exposure / adverse effects*
-
Peritoneal Neoplasms / chemically induced
-
Peritoneal Neoplasms / epidemiology
-
Pleural Neoplasms / chemically induced
-
Pleural Neoplasms / epidemiology
-
Pulmonary Fibrosis / chemically induced
-
Pulmonary Fibrosis / epidemiology
-
Tomography, X-Ray Computed
Substances
-
Environmental Pollutants
-
Mineral Fibers
-
Asbestos